Defining colchicine resistance/intolerance in patients with familial Mediterranean fever: a modified-Delphi consensus approach

Tarih
2021
Yazar
Lachmann, Helen J.
Gattorno, Marco
Gül, Ahmet
Hashkes, Philip J.
Kuemmerle-Deschner, Jasmin B.
de Benedetti, Fabrizio
Twilt, Marinka
Kone-Paut, Isabelle
Tsitsami, Elena
ÖZEN, SEZA
SAĞ, ERDAL
Ben-Chetrit, Eldad
Üst veri
Tüm öğe kaydını göster
Özet
Objectives. Colchicine is the main treatment for FMF. Although a number of individuals with FMF are intolerant/resistant to colchicine, there is no standard definition of colchicine resistance/intolerance. We developed a set of evidence-based core statements defining colchicine resistance/intolerance in patients with FMF that may serve as a guide for clinicians and health authorities.
Bağlantı
http://hdl.handle.net/20.500.12627/170668
https://doi.org/10.1093/rheumatology/keaa863
Koleksiyonlar